Published in J Med Genet on February 01, 2005
Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A (2008) 2.91
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet (2010) 1.31
No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50. Am J Hum Genet (2008) 1.29
Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatment. J Investig Med (2009) 1.27
Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry (2007) 1.26
Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome. Future Neurol (2009) 1.17
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet (2010) 1.14
Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol (2012) 0.84
Improved methodology for assessment of mRNA levels in blood of patients with FMR1 related disorders. BMC Clin Pathol (2009) 0.83
Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation. Brain Res (2012) 0.80
Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field. F1000Res (2013) 0.76
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet (2000) 6.73
Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology (2001) 6.55
Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology (1990) 4.42
Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain (2002) 4.05
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
Protein composition of the intranuclear inclusions of FXTAS. Brain (2005) 2.95
Sequence-directed curvature of DNA. Nature (1986) 2.89
Investigation of the flexibility of DNA using transient electric birefringence. Biopolymers (1981) 2.74
Evidence for the existence of stable curvature of DNA in solution. Proc Natl Acad Sci U S A (1984) 2.67
Sequence dependence of the curvature of DNA: a test of the phasing hypothesis. Biochemistry (1985) 2.60
Transcription of the FMR1 gene in individuals with fragile X syndrome. Am J Med Genet (2000) 2.46
Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet (2004) 2.33
Flexibility of single-stranded DNA: use of gapped duplex helices to determine the persistence lengths of poly(dT) and poly(dA). J Mol Biol (1999) 2.31
Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet (1991) 2.29
Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet (1999) 2.26
Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet (2000) 2.24
FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet (1999) 2.23
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Magnetic resonance evaluation of ventrolateral medullary compression in essential hypertension. J Neurosurg (1998) 2.10
DNA ring closure mediated by protein HU. J Biol Chem (1989) 2.09
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology (2005) 2.04
DNA typing in the forensic arena. Am J Hum Genet (1990) 2.01
Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA (1994) 2.01
Gel electrophoretic analysis of the geometry of a DNA four-way junction. J Mol Biol (1987) 1.99
Application of the method of phage T4 DNA ligase-catalyzed ring-closure to the study of DNA structure. II. NaCl-dependence of DNA flexibility and helical repeat. J Mol Biol (1990) 1.97
Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome. Nat Genet (1995) 1.95
Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA. Am J Med Genet (2000) 1.85
Bulge-induced bends in RNA: quantification by transient electric birefringence. J Mol Biol (1995) 1.84
A quantitative treatment of the kinetics of the folding transition of ribonuclease A. Biochemistry (1976) 1.83
Autosomal dominant transmission of the Pallister-Hall syndrome. J Pediatr (1993) 1.83
MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett (2000) 1.82
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology (2007) 1.80
Spinal cord infection: myelitis and abscess formation. AJNR Am J Neuroradiol (1998) 1.78
Geometry of a branched DNA structure in solution. Proc Natl Acad Sci U S A (1989) 1.78
Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med (2001) 1.78
Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg (1994) 1.78
Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology (2007) 1.77
Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet (2004) 1.77
Neurodevelopmental outcome of patients after the fontan operation: A comparison between children with hypoplastic left heart syndrome and other functional single ventricle lesions. J Pediatr (2000) 1.76
Aging in individuals with the FMR1 mutation. Am J Ment Retard (2004) 1.68
Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet (1995) 1.64
High-resolution CT imaging of carotid artery atherosclerotic plaques. AJNR Am J Neuroradiol (2008) 1.63
Brain structure and cognition in a community sample of elderly Latinos. Neurology (2002) 1.62
911 and emergency department use for chest pain: results of a media campaign. Ann Emerg Med (1994) 1.59
Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard (1998) 1.58
Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology (2006) 1.55
Solitary fibrous tumor of the paranasal sinuses: CT and MR appearance. AJNR Am J Neuroradiol (1996) 1.53
Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A (2005) 1.52
Sensory modulation dysfunction in children with attention-deficit-hyperactivity disorder. Dev Med Child Neurol (2001) 1.49
Human immunodeficiency virus type 1 (HIV-1) seroconversion during pregnancy does not increase the risk of perinatal transmission. Br J Obstet Gynaecol (1991) 1.47
Aggressive papillary middle ear tumors: a report of two cases with review of the literature. Neurosurgery (1994) 1.47
A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA. J Med Genet (2001) 1.44
Analysis of fluorescence energy transfer in duplex and branched DNA molecules. Biochemistry (1990) 1.44
Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav (2012) 1.44
Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry (1994) 1.42
Episodic memory in transient global amnesia: encoding, storage, or retrieval deficit? J Neurol Neurosurg Psychiatry (1999) 1.42
Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia (1999) 1.42
Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav (2012) 1.41
Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med (1998) 1.40
Nitrous oxide anesthesia-associated myelopathy. Arch Neurol (2000) 1.40
Psoriatic arthritis in British and Italian patients: a comparative clinical, radiologic, and scintigraphic study. J Rheumatol (1999) 1.39
Six-and-half years' experience with the St. Jude BioImplant porcine prosthesis. J Heart Valve Dis (1997) 1.39
The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptide. Proc Natl Acad Sci U S A (1995) 1.38
Electrophoretic evidence that single-stranded regions of one or more nucleotides dramatically increase the flexibility of DNA. Biochemistry (1994) 1.38
An analysis of autism in fifty males with the fragile X syndrome. Am J Med Genet (1986) 1.38
Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet (2005) 1.37
Sensory-modulation disruption, electrodermal responses, and functional behaviors. Dev Med Child Neurol (1999) 1.37